Some background on the formation of the online journal open medicine: http://cjnr.mcgill.ca/archive/38/edit38_2_Gottlieb.htm
Based on some of the horror stories I’ve heard Canadians tell, I don’t agree that their system is superior.
The one area where they appear to excel is prescription drugs, but that’s misleading because they have price controls. We could do the same thing, but if we did, then the drug companies would not have much incentive to invent drugs. Right now, the Canadians have the best of both worlds. They benefit from the US consumer’s willingness to pick up the tab for drug research, so they can fix their prices at very low levels without significantly impacting drug research. They are the classical “free rider.” But we can’t all be free riders. A better strategy than controlling prices would be to try to force the Canadians and other regulated nations to pick up their fair share of the research costs.
There’s an asterisk beside the Canadian treatment results..*
* If you can get it.
When you get down to the part under RESULTS to the "end stage renal disease" they neglect to note that African-Americans have a far greater incidence of this than do all other Americans.
Conclusion: totally intellectually dishonest leftwingnut report.